208 related articles for article (PubMed ID: 34392078)
1. Acute myelitis and ChAdOx1 nCoV-19 vaccine: Casual or causal association?
Vegezzi E; Ravaglia S; Buongarzone G; Bini P; Diamanti L; Gastaldi M; Prunetti P; Rognone E; Marchioni E
J Neuroimmunol; 2021 Oct; 359():577686. PubMed ID: 34392078
[TBL] [Abstract][Full Text] [Related]
2. Acute Transverse Myelitis (ATM):Clinical Review of 43 Patients With COVID-19-Associated ATM and 3 Post-Vaccination ATM Serious Adverse Events With the ChAdOx1 nCoV-19 Vaccine (AZD1222).
Román GC; Gracia F; Torres A; Palacios A; Gracia K; Harris D
Front Immunol; 2021; 12():653786. PubMed ID: 33981305
[TBL] [Abstract][Full Text] [Related]
3. MOG encephalomyelitis after vaccination against severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2): case report and comprehensive review of the literature.
Jarius S; Bieber N; Haas J; Wildemann B
J Neurol; 2022 Oct; 269(10):5198-5212. PubMed ID: 35737110
[TBL] [Abstract][Full Text] [Related]
4. Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine in children aged 6-17 years: a preliminary report of COV006, a phase 2 single-blind, randomised, controlled trial.
Li G; Cappuccini F; Marchevsky NG; Aley PK; Aley R; Anslow R; Bibi S; Cathie K; Clutterbuck E; Faust SN; Feng S; Heath PT; Kerridge S; Lelliott A; Mujadidi Y; Ng KF; Rhead S; Roberts H; Robinson H; Roderick MR; Singh N; Smith D; Snape MD; Song R; Tang K; Yao A; Liu X; Lambe T; Pollard AJ;
Lancet; 2022 Jun; 399(10342):2212-2225. PubMed ID: 35691324
[TBL] [Abstract][Full Text] [Related]
5. MOG-antibody-associated longitudinal extensive myelitis after ChAdOx1 nCoV-19 vaccination.
Dams L; Kraemer M; Becker J
Mult Scler; 2022 Jun; 28(7):1159-1162. PubMed ID: 34931927
[TBL] [Abstract][Full Text] [Related]
6. Bilateral Atypical Optic Neuritis following ChAdOx1_nCoV-19 Vaccination: A Putative Plausibility.
Saluja P; Kohli GM; More A; Shetty SB; Sen A
Ocul Immunol Inflamm; 2023 Aug; 31(6):1250-1253. PubMed ID: 36256905
[TBL] [Abstract][Full Text] [Related]
7. Tolerability and immunogenicity of an intranasally-administered adenovirus-vectored COVID-19 vaccine: An open-label partially-randomised ascending dose phase I trial.
Madhavan M; Ritchie AJ; Aboagye J; Jenkin D; Provstgaad-Morys S; Tarbet I; Woods D; Davies S; Baker M; Platt A; Flaxman A; Smith H; Belij-Rammerstorfer S; Wilkins D; Kelly EJ; Villafana T; Green JA; Poulton I; Lambe T; Hill AVS; Ewer KJ; Douglas AD
EBioMedicine; 2022 Nov; 85():104298. PubMed ID: 36229342
[TBL] [Abstract][Full Text] [Related]
8. Reversible radiculomyelitis after ChAdOx1 nCoV-19 vaccination.
Spataro R; Fisco G; La Bella V
BMJ Case Rep; 2022 Feb; 15(2):. PubMed ID: 35110289
[TBL] [Abstract][Full Text] [Related]
9. Neurological symptoms and neuroimaging alterations related with COVID-19 vaccine: Cause or coincidence?
Corrêa DG; Cañete LAQ; Dos Santos GAC; de Oliveira RV; Brandão CO; da Cruz LCH
Clin Imaging; 2021 Dec; 80():348-352. PubMed ID: 34507266
[TBL] [Abstract][Full Text] [Related]
10. Immunogenicity and reactogenicity against the SARS-CoV-2 variants following heterologous primary series involving CoronaVac, ChAdox1 nCov-19 and BNT162b2 plus BNT162b2 booster vaccination: An open-label randomized study in healthy Thai adults.
Niyomnaitham S; Quan Toh Z; Wongprompitak P; Jansarikit L; Srisutthisamphan K; Sapsutthipas S; Jantraphakorn Y; Mingngamsup N; Licciardi PV; Chokephaibulkit K
Hum Vaccin Immunother; 2022 Nov; 18(6):2091865. PubMed ID: 35816053
[TBL] [Abstract][Full Text] [Related]
11. Clinical characteristics, radiological features and prognostic factors of transverse myelitis following COVID-19 vaccination: A systematic review.
Ostovan VR; Sahraian MA; Karazhian N; Rostamihosseinkhani M; Salimi M; Marbooti H
Mult Scler Relat Disord; 2022 Oct; 66():104032. PubMed ID: 35858499
[TBL] [Abstract][Full Text] [Related]
12. Longitudinal extensive transverse myelitis following ChAdOx1 nCOV-19 vaccine: a case report.
Tan WY; Yusof Khan AHK; Mohd Yaakob MN; Abdul Rashid AM; Loh WC; Baharin J; Ibrahim A; Ismail MR; Inche Mat LN; Wan Sulaiman WA; Basri H; Hoo FK
BMC Neurol; 2021 Oct; 21(1):395. PubMed ID: 34641797
[TBL] [Abstract][Full Text] [Related]
13. Longitudinally extensive transverse myelitis following ChAdOx1 nCoV-19 vaccine.
Shetty AJ; Rastogi A; Jha V; Sudhayakumar A
J Postgrad Med; 2022; 68(3):179-181. PubMed ID: 35975341
[TBL] [Abstract][Full Text] [Related]
14. Immune thrombocytopenic purpura after vaccination with COVID-19 vaccine (ChAdOx1 nCov-19).
Paulsen FO; Schaefers C; Langer F; Frenzel C; Wenzel U; Hengel FE; Bokemeyer C; Seidel C
Blood; 2021 Sep; 138(11):996-999. PubMed ID: 34297792
[No Abstract] [Full Text] [Related]
15. A Case Report of Immune Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination.
Kim G; Choi EJ; Park HS; Lee JH; Lee JH; Lee KH
J Korean Med Sci; 2021 Nov; 36(43):e306. PubMed ID: 34751013
[TBL] [Abstract][Full Text] [Related]
16. Superficial venous thrombosisas a possible consequence of ChAdOx1 nCoV-19 vaccine: two case reports.
Sah MK; Singh BM; Sinha P; Devkota P; Yadav SK; Shrestha J; Shrestha A
J Med Case Rep; 2022 May; 16(1):182. PubMed ID: 35524323
[TBL] [Abstract][Full Text] [Related]
17. Sensory Guillain-Barre syndrome following the ChAdOx1 nCov-19 vaccine: Report of two cases and review of literature.
Min YG; Ju W; Ha YE; Ban JJ; Lee SA; Sung JJ; Shin JY
J Neuroimmunol; 2021 Oct; 359():577691. PubMed ID: 34416410
[TBL] [Abstract][Full Text] [Related]
18. Herpes simplex virus retinitis following ChAdOx1 nCoV- 19 (Covishield) vaccination for SARS CoV 2: A case report.
Singh J; More A; Shetty SB; Chaskar P; Sen A
Ocul Immunol Inflamm; 2022 Jul; 30(5):1282-1285. PubMed ID: 35587646
[TBL] [Abstract][Full Text] [Related]
19. Immune response and safety of heterologous ChAdOx1-nCoV-19/mRNA-1273 vaccination compared with homologous ChAdOx1-nCoV-19 or homologous mRNA-1273 vaccination.
Sheng WH; Chang SY; Lin PH; Hsieh MJ; Chang HH; Cheng CY; Yang HC; Pan CF; Ieong SM; Chao TL; Chen JP; Cheng SH; Chang SC
J Formos Med Assoc; 2022 Apr; 121(4):766-777. PubMed ID: 35305895
[TBL] [Abstract][Full Text] [Related]
20. A case of longitudinally extensive transverse myelitis following vaccination against Covid-19.
Pagenkopf C; Südmeyer M
J Neuroimmunol; 2021 Sep; 358():577606. PubMed ID: 34182207
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
